13D/13G Filings - Arcturus Therapeutics Holdings Inc. (ARCT)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-05-22
5:21 pm
Purchase
2020-05-20 13D Arcturus Therapeutics Holdings Inc.
ARCT
Ultragenyx Pharmaceutical Inc.
RARE
3,000,000
14.600%
321,964increase
(+12.02%)
Filing
History
2020-04-27
4:05 pm
Purchase
2020-04-16 13G Arcturus Therapeutics Holdings Inc.
ARCT
Cormorant Asset Management LP 1,144,537
5.760%
1,144,537increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2